$85.67+13.37% · 3M
Moving avg
1W+6.37%
1M+7.42%
3M+13.37%
6M-2.93%
YTD-1.87%
1Y+38.47%
3Y+49.02%
5Y+11.20%
52-week range
$51.7968% of range$101.40
Company health
Value4/6
Growth6/6
Profitability5/6
Health5/6
Dividend0/6
Bull vs bear
Strengths
- Analysts see 20% upside to a $102 target
- Analyst consensus is "Buy"
- High return on equity (1304%)
- Revenue compounding 18% a year
- Net cash on the balance sheet
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$11.55B
Enterprise value
$9.73B
P/E ratio (TTM)
17.34x
P/S ratio (TTM)
3.28x
EV/EBITDA
11.05x
Per share & returns
EPS (TTM)
$4.33
Dividend yield
0.00%
Beta (1Y)
0.95
30-day change
+7.42%
Trading
Volume (24h)
854.39K
Previous close
$85.15
Shares outstanding
134.86M
About Globus Medical, Inc.
Sector
Healthcare
Industry
Medical - Devices
Exchange
NYSE
Symbol
GMED
Globus Medical, Inc. is a large-cap healthcare company in the Medical - Devices industry. Its shares are listed on NYSE (United States) and trade under the ticker GMED.
Frequently asked questions
What is Globus Medical, Inc.'s market cap?
Globus Medical, Inc. (GMED) has a market capitalization of $11.55B.
What is Globus Medical, Inc.'s P/E ratio?
Globus Medical, Inc. trades at a price-to-earnings (P/E) ratio of 17.34.
What exchange does GMED trade on?
GMED trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 364.60-0.25%
$356.57B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.68-0.42%
$288.82B cap
AstraZeneca PLCLON: AZN
£116.30-0.62%
$243.13B cap